Ephedrine Market
According to Intent Market Research, the Ephedrine Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 4.9% to touch USD 2.5 billion by 2030. The Ephedrine Market is dominated by key players such as Mylan N.V., Teva Pharmaceutical Industries Ltd., Amgen Inc., Eli Lilly and Co., Sandoz (Novartis), Sun Pharmaceutical Industries Ltd., AbbVie Inc., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Lupin Pharmaceuticals, Inc., AstraZeneca, GlaxoSmithKline, Cipla Ltd., Sierra Sage Herbs, LLC, Herbalife Nutrition Ltd